Related Experiment Video
Updated: Aug 24, 2025
08:24
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
7.0K
The New SNOMED CT International Medicinal Product Model
Olivier Bodenreider1, Julie James2
1U.S. National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA.
CEUR Workshop Proceedings
|October 24, 2022
Summary
The new SNOMED CT international medicinal product model offers a comprehensive approach to clinical drugs. This updated model enhances organization and ensures compliance with global standards.
Area of Science:
- Health Informatics
- Medical Terminology
- Drug Classification
Background:
- The need for a standardized international medicinal product model is crucial for accurate drug representation in healthcare systems.
- Existing models may lack comprehensive coverage or logical definitions for clinical drugs.
Purpose of the Study:
- To introduce and detail the new SNOMED CT international medicinal product model.
- To highlight key features including entity types, interrelations, definitional attributes, and groupers.
Main Methods:
- Presentation of the core components of the SNOMED CT medicinal product model.
- Focus on entity relationships, attributes for clinical drugs, and categorization of groupers.
- Illustrative comparison between the previous and new models.
Main Results:
- The new model provides a comprehensive representation of clinical drugs.
- Logical definitions with necessary and sufficient conditions are established for all medicinal product entities.
- Improved high-level organization is achieved through distinct grouper categories.
Conclusions:
- The enhanced SNOMED CT medicinal product model offers significant benefits for clinical drug representation.
- It ensures logical consistency, better organization, and adherence to international standards.
- Implementation status as of July 2018 indicates progress in adopting the new model.
Related Concept Videos
01:17Drug Nomenclature
2.1K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.1K
01:02Prescription, Nonprescription and Orphan Drugs
830
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
830
01:25Drug Regulation
1.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.7K